CRISPR THERAPEUTICS AG
CRSP · NASDAQ
Updated at 2026-10-13 14:20:22
- Today's High
- $51.12
- Today’s Low
- $50.04
%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23150%3B%26%23135%3B%26%23230%3B%26%23161%3B%26%23163%3B%26%23230%3B%26%23154%3B%26%23151%3B%26%23232%3B%26%23167%3B%26%23146%3B%22%20d%3D%22M48.3363%2013.4132H60.2082L46.795%205.72205e-06V11.8719C46.795%2012.7231%2047.4851%2013.4132%2048.3363%2013.4132Z%22%20fill%3D%22var(--fill-0%2C%20%23474741)%22%2F%3E%0A%3Cpath%20id%3D%22%26%23230%3B%26%23148%3B%26%23190%3B%26%23229%3B%26%23164%3B%26%23167%3B%26%23233%3B%26%23149%3B%26%23156%3B%22%20fill-rule%3D%22evenodd%22%20clip-rule%3D%22evenodd%22%20d%3D%22M11.3812%2020.3725C16.7977%2014.9559%2025.5803%2014.9559%2030.9969%2020.3725C36.413%2025.789%2036.4131%2034.5707%2030.9969%2039.9872C26.0109%2044.973%2018.1729%2045.3699%2012.7335%2041.1769L2.54298%2051.3684L0%2048.8254L10.1915%2038.6329C5.99993%2033.1937%206.39609%2025.3579%2011.3812%2020.3725ZM28.4539%2022.9155C24.4418%2018.9033%2017.9363%2018.9033%2013.9241%2022.9155C9.91245%2026.9275%209.91241%2033.4322%2013.9241%2037.4442C17.9362%2041.4562%2024.4418%2041.4562%2028.4539%2037.4442C32.4656%2033.4322%2032.4656%2026.9275%2028.4539%2022.9155Z%22%20fill%3D%22var(--fill-0%2C%20%235D5D56)%22%2F%3E%0A%3C%2Fg%3E%0A%20%20%3C%2Fsvg%3E%0A%3C%2Fsvg%3E%0A)
Candlestick trends are for reference. Refer to the trading page for actual data.
Key Statistics
- Previous Open
- $52.91
- Previous Close
- $51.55
- Volume
- 1.1M
- Market Cap
- $4.98B
- P/E Ratio
- --
- EPS
- $-4.76
Previous Day Range
52-Week Range
Company Overview
- Sector
- HEALTHCARE
- Industry
- Biotechnology
- Sub-industry
- BIOTECHNOLOGY
- Headquarters
- BAARERSTRASSE 14, ZUG, SWITZERLAND, 6300
- Country
- CH
- Listing Date
- 2016-10-19
- Fiscal Year End
- December
- Shares Outstanding
- 96.45M
- CIK
- 0001674416
- Website
- crisprtx.com
CRISPR Therapeutics AG, a gene editing company, focuses on the development of gene-based transformative drugs for serious human diseases. The company is headquartered in Zug, Switzerland.
Financial Metrics
Revenue
2026-06-30
$10.18M
2026-03-31
$1.45M
2025-12-31
$864K
2025-09-30
$889K
Operating Expenses
2026-06-30
$80.4M
2026-03-31
$81.45M
2025-12-31
$96.26M
2025-09-30
$68.25M
Net Income
2026-06-30
-$91.15M
2026-03-31
-$122.93M
2025-12-31
-$130.61M
2025-09-30
-$106.44M
Net Profit Margin
2026-06-30
-895.33%
2026-03-31
-8.43K%
2025-12-31
-15.11K%
2025-09-30
-11.97K%
Earnings Per Share
2026-06-30
$-0.94
2026-03-31
$-1.28
2025-12-31
$-1.37
2025-09-30
$-1.17
Earnings Before Interest, Taxes, Depreciation, and Amortization
2026-06-30
-$110.51M
2026-03-31
-$117.77M
2025-12-31
-$124.33M
2025-09-30
-$101.38M
Effective Tax Rate
2026-06-30
-1.06%
2026-03-31
-0.68%
2025-12-31
-0.47%
2025-09-30
-0.58%
| Item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
| Revenue | $10.18M | $1.45M | $864K | $889K |
| Operating Expenses | $80.4M | $81.45M | $96.26M | $68.25M |
| Net Income | -$91.15M | -$122.93M | -$130.61M | -$106.44M |
| Net Profit Margin | -895.33% | -8.43K% | -15.11K% | -11.97K% |
| Earnings Per Share | $-0.94 | $-1.28 | $-1.37 | $-1.17 |
| Earnings Before Interest, Taxes, Depreciation, and Amortization | -$110.51M | -$117.77M | -$124.33M | -$101.38M |
| Effective Tax Rate | -1.06% | -0.68% | -0.47% | -0.58% |
FAQs
Risk Warning
Stock prices can be highly volatile and may rise or fall sharply in a short period. Digital asset and derivative products involve additional risks such as leverage and liquidity. Content on this page is for reference only and does not constitute investment advice. Product availability and access may vary by region and applicable regulations.